What we're reading, January 28, 2016: Massachusetts' attorney general is threatening to sue Gilead Sciences over the high prices of its hepatitis C drugs; Anthem reports losses on Obamacare health plans; and consumers are satisfied with health coverage and limited networks.
In Massachusetts, the attorney general has warned Gilead Sciences that its high prices for Sovaldi and Harvoni may be illegal and violate the state’s law for fair trade practice. The Attorney general is not looking to sue the drugmaker for larger rebates or discounts, as others have done in the past, but for overpricing its products and violating consumer protection law, according to The Boston Globe.
UnitedHealth is not the only insurer feeling the pain from Affordable Care Act health plans. Now Anthem has announced that exchange plans caused the company to miss analyst expectations for fourth quarter earnings, reported Reuters. Anthem had enrolled 30% fewer beneficiaries than expected, which made the costs of running the business too high. However, Anthem CEO Joseph Swedish said enrollment data for 2016 so far looks a little better.
A new survey from Kaiser Family Foundation found that a majority of consumers don’t mind limited networks of doctors and hospitals to restrain prices and were satisfied with their coverage and the cost. However, people without insurance were less pleased and usually did not have coverage because they found it too expensive. In addition, healthcare is no longer a top priority for voters in the upcoming presidential election.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More